InsidersTradesSigma
Follow the 서린바이오 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 서린바이오 has logged 1 reports. Market capitalisation: €36.6bn. The latest transaction was disclosed on 2 April 2026 (Purchase). Among the most active insiders: 강미옥. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
서린바이오 is a healthcare and pharmaceutical company listed on the XKRX. It focuses on developing innovative biopharmaceutical solutions.